Clinical trials
Respiratory Distress Syndrome trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 13 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 10 |
| Recruiting | 8 |
| Terminated | 7 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital Tuebingen | 7 |
| Charite University, Berlin, Germany | 4 |
| Bayer | 2 |
| European Society of Anaesthesiology | 2 |
| Goethe University | 2 |
| Johannes Gutenberg University Mainz | 2 |
| University Hospital Freiburg | 2 |
| University Hospital, Bonn | 2 |
| AstraZeneca | 1 |
| BioAegis Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 48 |
| Acute Lung Injury | 8 |
| Respiratory Insufficiency | 8 |
| COVID-19 | 7 |
| Pneumonia | 4 |
| Hypoxia | 3 |
| Pneumothorax | 3 |
| Pulmonary Atelectasis | 3 |
| Sepsis | 3 |
| Shock, Cardiogenic | 3 |
Trials
Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.